Publication: The Evolving Landscape of Brain Metastasis.
Loading...
Identifiers
Publication date
Advisors
Journal Title
Journal ISSN
Volume Title
Publishers
Cell Press
Metrics
Export
Abstract
Metastasis, involving the spread of systemic cancer to the brain, results in neurologic disability and death. Current treatments are largely palliative in nature; improved therapeutic approaches represent an unmet clinical need. However, recent experimental and clinical advances challenge the bleak long-term outcome of this disease. Encompassing key recent findings in epidemiology, genetics, microenvironment, leptomeningeal disease, neurocognition, targeted therapy, immunotherapy, and prophylaxis, we review preclinical and clinical studies to provide a comprehensive picture of contemporary research and the management of secondary brain tumors.
Description
We thank members of our laboratories for helpful discussions. We are grateful for funding from the National Cancer Institute 2P30CA008748-48, to A.B.), Mundipharma (E.L.R.), Amgen (E.L.R.), German Cancer Aid (Deutsche Krebshilfe), Translational Oncology Program, the Prevent Brain Metastasis Consortium (F.W.), MINECO-Retos (SAF2014-57243-R, to M.V.), MINECO-Europa Excelencia (SAF2015-62547-ERC, to M.V.), IX FERO Grant for Research in Oncology (M.V.), Bristol-Myers Squibb Melanoma Research Alliance Young Investigator Award 2017 (M.V.), and the Beug Foundation Prize for Metastasis Research 2017 (M.V.). M.V. is a Ramon y Cajal Investigator (RYC-2013-13365).
MeSH Terms
DeCS Terms
Bibliographic citation
Trends Cancer . 2018 Mar;4(3):176-196